| scholarly article | Q13442814 |
| P50 | author | Kanneboyina Nagaraju | Q27662260 |
| Heather Gordish-Dressman | Q57474854 | ||
| P2093 | author name string | Qing Yu | |
| Kathleen S Tatem | |||
| James L Quinn | |||
| Aditi Phadke | |||
| P2860 | cites work | Can animal models of disease reliably inform human studies? | Q21563449 |
| Drug development: Raise standards for preclinical cancer research | Q22348097 | ||
| A call for transparent reporting to optimize the predictive value of preclinical research | Q24289327 | ||
| Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency | Q28258826 | ||
| Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype | Q28475580 | ||
| Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse | Q28482090 | ||
| Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene | Q28587632 | ||
| Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies | Q33912061 | ||
| Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures | Q33975979 | ||
| Measuring normal and pathological anxiety-like behaviour in mice: a review. | Q34420641 | ||
| Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice | Q34556906 | ||
| Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy | Q34769964 | ||
| The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review | Q35071470 | ||
| Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies | Q35690856 | ||
| Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy | Q36841572 | ||
| The Open-Field Test: a critical review. | Q36854940 | ||
| Aged rats: sex differences and responses to chronic stress | Q42595734 | ||
| Effects of strain, sex, and illumination on open-field behavior of rats | Q43321003 | ||
| Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake-sleep states | Q43678437 | ||
| Evaluation of Lewis and SHR rat strains as a genetic model for the study of anxiety and pain. | Q51056819 | ||
| P433 | issue | 91 | |
| P304 | page(s) | 51785 | |
| P577 | publication date | 2014-09-29 | |
| P1433 | published in | Journal of Visualized Experiments | Q954500 |
| P1476 | title | Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases |
| Q57792603 | 5-HT receptor-induced morphological reorganization of PKCγ-expressing interneurons gates inflammatory mechanical allodynia in rat |
| Q61814402 | A Hydrolyzed Chicken Extract CMI-168 Enhances Learning and Memory in Middle-Aged Mice |
| Q48505622 | A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy. |
| Q47652347 | A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activity |
| Q28266068 | Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear |
| Q64893464 | Antioxidant, Hypoglycemic, and Neurobehavioral Effects of a Leaf Extract of Avicennia marina on Autoimmune Diabetic Mice. |
| Q58768005 | Cholinergic Nerve Differentiation of Mesenchymal Stem Cells Derived from Long-Term Cryopreserved Human Dental Pulp In Vitro and Analysis of Their Motor Nerve Regeneration Potential In Vivo |
| Q90192805 | Commercial Formulation of Chlorpyrifos Alters Neurological Behaviors and Fertility |
| Q90318657 | Complex interaction of dietary fat and Alaskan bog blueberry supplementation influences manganese mediated neurotoxicity and behavioral impairments |
| Q92209988 | Computer Methods for Automatic Locomotion and Gesture Tracking in Mice and Small Animals for Neuroscience Applications: A Survey |
| Q89679175 | Corticotropin releasing factor-overexpressing mouse is a model of chronic stress-induced muscle atrophy |
| Q61800872 | Decreased dopamine in striatum and difficult locomotor recovery from MPTP insult after exposure to radiofrequency electromagnetic fields |
| Q47376779 | Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus |
| Q92305969 | Establishing an effective dose for chronic intracerebroventricular administration of clozapine in mice |
| Q48240848 | Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. |
| Q28396884 | Intranasal Chromium Induces Acute Brain and Lung Injuries in Rats: Assessment of Different Potential Hazardous Effects of Environmental and Occupational Exposure to Chromium and Introduction of a Novel Pharmacological and Toxicological Animal Model |
| Q47160714 | MR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat. |
| Q30835268 | Maternal cortisol stimulates neurogenesis and affects larval behaviour in zebrafish |
| Q50345655 | Modulation of social deficits and repetitive behaviors in a mouse model of autism: the role of the nicotinic cholinergic system. |
| Q90438401 | Neuroectodermal stem cells: A remyelinating potential in acute compressed spinal cord injury in rat model |
| Q64227152 | Neuromuscular dysfunction, independent of gait dysfunction, modulates trabecular bone homeostasis in mice |
| Q59136651 | Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction |
| Q41969953 | Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors |
| Q47590403 | Postnatal Subacute Benzo(a)Pyrene Exposure Caused Neurobehavioral Impairment and Metabolomic Changes of Cerebellum in the Early Adulthood Period of Sprague-Dawley Rats. |
| Q61809637 | Retracted: Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes |
| Q47443833 | Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis |
| Q64256887 | Sequential Photoperiodic Programing of Serotonin Neurons, Signaling and Behaviors During Prenatal and Postnatal Development |
| Q48017691 | Suite of clinically relevant functional assays to address therapeutic efficacy and disease mechanism in the dystrophic mdx mouse |
| Q92831388 | The Role of BTBD9 in Striatum and Restless Legs Syndrome |
| Q58110688 | The potential reproductive toxicity of tannery effluent to the estrous cycle and ovarian follicular dynamics of female Swiss mice |
| Q96640138 | Transient effects of chemotherapy for testicular cancer on mouse behaviour |
| Q38633484 | Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice. |
| Q48355383 | URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors. |
| Q55109195 | Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice. |
| Q34548198 | Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor |
Search more.